Paid Clinical Trials in Bend, OR
As of August 2026, 60 paid clinical trials are recruiting in Bend, Oregon. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Bend offers studies at sites including Saint Charles Health System for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Interstitial Lung Disease, Malignant Solid Neoplasm, Prostate Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Bend
Trials by drug in Bend
Filter results
60 clinical trials
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Caris Biorepository Research Protocol
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Glycemic Metrics and Patterns in People With and Without Prediabetes
AETOS Shoulder System
Family Communications After Genetic Testing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
E-Mindfulness Approaches for Living After Breast Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Top Research Study Locations in Bend
Researchers run research studies in Bend, OR at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Charles Health System | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Prostate Adenocarcinoma | 41 |
| Summit Health | Interstitial Lung Disease, Pulmonary Hypertension, Idiopathic Pulmonary Fibrosis (IPF) | 4 |
| Bend Memorial Clinic | Cancer, Early Detection of Cancer, Minimal Residual Disease | 2 |
| Bend Memorial Hospital | Idiopathic Pulmonary Fibrosis | 1 |
| Bend Surgery Center | Lumbar Spinal Stenosis | 1 |
| Cascade Surg Ctr | Lumbar Spinal Stenosis | 1 |
| Center for Orthopedics and Neurosurgical Care | Shoulder Arthritis, Shoulder Osteoarthritis | 1 |
| Central Oregon Surg Ctr | Lumbar Spinal Stenosis | 1 |
| Central Oregon Surgical Institute | Lumbar Spinal Stenosis | 1 |
| Dermatology Health Specialists | Cutaneous Squamous Cell Carcinoma (CSCC) | 1 |
| Deschutes County Behavioral Health EASA | Family Members, Implementation | 1 |
| Deschutes Surgery Center | Lumbar Spinal Stenosis | 1 |
| Diabetes and Obesity Care | Pre Diabetes | 1 |
| St Charles Bend Cancer Center | Breast Neoplasms | 1 |
| St Charles Medical Center | Colorectal Neoplasms | 1 |
| St. Charles Health System | Non-small Cell Lung Cancer | 1 |
| St. Charles Health System, Inc | Non-small Cell Lung Cancer | 1 |
| St. Charles Health System, Inc. DBA St. Charles Medical Center | Triple Negative Breast Cancer | 1 |
| Summit Health Eastside Clinic | Healthy Volunteers, Pulmonary Arterial Hypertension | 1 |
| USA003 | Interstitial Lung Disease, Pulmonary Hypertension | 1 |
Active & Upcoming Studies in Bend (2026)
Recruiting trials in Bend grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (37 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Cardiovascular (6 active studies)
- A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD · Phase 3 · Liquidia Technologies, Inc.
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) · Phase 3 · Insmed Incorporated
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Diabetes & metabolic (1 active study)
- Glycemic Metrics and Patterns in People With and Without Prediabetes · Abbott Diabetes Care
Common conditions studied in Bend
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Interstitial Lung Disease (3 active studies)
- Malignant Solid Neoplasm (3 active studies)
- Prostate Adenocarcinoma (3 active studies)
- Pulmonary Hypertension (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Bend
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- NRG Oncology
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Bend?
There are approximately 60 recruiting clinical trials in Bend, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Bend pay participants?
Most recruiting trials in Bend compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Bend?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Bend?
The most common conditions under active study in Bend include Anatomic Stage II Breast Cancer AJCC v8 (4), Interstitial Lung Disease (3), Malignant Solid Neoplasm (3), Prostate Adenocarcinoma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Bend?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Bend on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Bend?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Bend?
Recruiting research sites in Bend include Saint Charles Health System, Summit Health, Bend Memorial Clinic, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Bend right now?
The largest active categories in Bend are Cancer & tumors (37), Cardiovascular (6), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.